Jubilant Organosys changes name to Jubilant Life Sciences

Jubilant Organosys Ltd, a pharmaceutical and life sciences company, said it changed its name as Jubilant Life Sciences Ltd with effect from 1st October.

On Friday, Jubilant Organosys shares declined 1.7% to Rs333 on the Bombay Stock Exchange, while the benchmark Sensex gained 1.9% to 20,445 points.

User

Maruti Suzuki sales in September up 30% to 108,006 units

Maruti Suzuki India (MSI) reported its highest-ever monthly sales of 108,006 units in September, translating into a 29.7% increase vis-a-vis the year-ago period.

Sales in the same month last year stood at 83,306 units, MSI said in a statement.
"This is the highest ever total monthly sales by the company. The previous highest was 104,791 units in August 2010," it added.

This was the fourth time this fiscal that the company's monthly sales figure crossed the one lakh mark. MSI also posted its best-ever sales of 95,148 units in the domestic market during the month, a 32.9% increase from 71,594 units in September, 2009.

MSI's exports increased by 9.8% in September 2010, to 12,858 units from 11,712 units in the year-ago period, the company added.

On Friday, Maruti Suzuki shares ended 2.9% up at Rs1,482 on the Bombay Stock Exchange, while the benchmark Sensex gained 1.9% to 20,445 points.

User

Ambuja Cements despatches rise 8.8% to 1.5mt in September

Ambuja Cements Ltd said its cement despatches increased 8.8% to 1.5 million tonnes (mt) in September 2010 compared to 1.36mt a year ago.

Cement production of the company increased by 7.3% to 1.48mt in September 2010 as against 1.38mt in the same month last year, Ambuja Cements said a regulatory filing.

Dispatches during January-September 2010 stood at 15.1mt against 14mt in the same period last year, while production increased to 15.1mt, compared to 14mt in January-September 2009.

On Friday, Ambuja Cements shares ended 0.9% up at Rs141 on the Bombay Stock Exchange, while the benchmark Sensex gained 1.9% to 20,445 points.

User

COMMENTS

vinod gupta

6 years ago

the sequential comparison is more valid, hoeever if you are comparing with last year, you should compare the mkt price and valuation metrics like forward PE RATIO AND EV/EBITDA

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)